Battle between Vertex, insurers leads to crushing CF drug costs
The cost of the cystic fibrosis medicine that his 2-year-old daughter, Ali, had recently started taking was about to climb from just $180 out of pocket each year to a whopping $43,600 in 2023. The dramatic change was due to a decision by the drug’s manufacturer, Vertex Pharmaceuticals, to slash the amount of financial assistance that it offers to patients this year. advertisement So last November, Brickey scrambled to find a solution, quickly shifting his daughter to a different, more affordable health plan that will mean the drug, called Orkambi, will cost $7,500 this year. Although the price tag is much less than if he had stayed with his previous insurer, he remains upset at the unexpected shock and aggravation — and the far higher expense. “We felt pretty helpless. We talked about what we could do financially, like if we needed to sell our house … but that would only help for so long,” said Brickey, a hospital nurse in Santaquin, Utah, where he lives with his wife, who is a kinderg
D an Brickey was stunned when he learned the news. The cost of the cystic fibrosis medicine that his 2-year-old daughter, Ali, had recently started taking was about to climb from just $180 out of pocket each year to a whopping $43,600 in 2023. The dramatic change was due to a decision by the drug’s manufacturer, Vertex Pharmaceuticals, to slash the amount of financial assistance that it offers to patients this year. Advertisement So last November, Brickey scrambled to find a solution, quickly shifting his daughter to a different, more affordable health plan that will mean the drug, called Orka
Explore this link on the map →related reading
- Inside the Mafia of Pharma Pricing - BIG by Matt Stollerthebignewsletter.com
- 392: Someone Else's Money - This American Lifethisamericanlife.org
- INDIVIDUAL & FAMILY HEALTH INSURANCE PLANS & Coverage | Aetnaaetnacvshealth.com
- New Genzyme pill will cost patients $310,250 a year - The Boston Globeweb.archive.org
- The Ozempocalypse Is Nigh - by Scott Alexanderastralcodexten.com
- A reimbursement framework for artificial intelligence in healthcare | npj Digital Medicinenature.com
- How Paytient Pays for Itselfpaytient.com
- We wish we’d written that: STAT staffers' favorite stories of 2022statnews.com
- Curious cases of financial engineering in biotechowlposting.com
- Joe Biden Lowered Drug Prices. Does Anyone Care? - The Atlantictheatlantic.com
- Why fixing the IRA matters to all of us - RApportrapport.bio
- Why are our medicines so expensive? Spoiler: Not for the reasons you are being told… - PMCncbi.nlm.nih.gov